BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35089933)

  • 1. Evaluation of a structured treatment discontinuation in patients with inoperable alveolar echinococcosis on long-term benzimidazole therapy: A retrospective cohort study.
    Deibel A; Stocker D; Meyer Zu Schwabedissen C; Husmann L; Kronenberg PA; Grimm F; Deplazes P; Reiner CS; Müllhaupt B
    PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010146. PubMed ID: 35089933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome after Discontinuing Long-Term Benzimidazole Treatment in 11 Patients with Non-resectable Alveolar Echinococcosis with Negative FDG-PET/CT and Anti-EmII/3-10 Serology.
    Ammann RW; Stumpe KD; Grimm F; Deplazes P; Huber S; Bertogg K; Fischer DR; Müllhaupt B
    PLoS Negl Trop Dis; 2015; 9(9):e0003964. PubMed ID: 26389799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. F-18-fluorodeoxyglucose (FDG) positron-emission tomography of Echinococcus multilocularis liver lesions: prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapy.
    Stumpe KD; Renner-Schneiter EC; Kuenzle AK; Grimm F; Kadry Z; Clavien PA; Deplazes P; von Schulthess GK; Muellhaupt B; Ammann RW; Renner EL
    Infection; 2007 Feb; 35(1):11-8. PubMed ID: 17297583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structured treatment interruption in patients with alveolar echinococcosis.
    Reuter S; Buck A; Manfras B; Kratzer W; Seitz HM; Darge K; Reske SN; Kern P
    Hepatology; 2004 Feb; 39(2):509-17. PubMed ID: 14768005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of benzimidazole therapy duration with PET/CT in inoperable patients with alveolar echinococcosis.
    Husmann L; Gruenig H; Reiner CS; Deibel A; Ledergerber B; Liberini V; Skawran S; Muehlematter UJ; Messerli M; Hasse B; Muellhaupt B; Huellner MW
    Sci Rep; 2022 Jul; 12(1):11392. PubMed ID: 35794149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of delayed 18F-FDG PET imaging in the follow-up of patients with alveolar echinococcosis.
    Caoduro C; Porot C; Vuitton DA; Bresson-Hadni S; Grenouillet F; Richou C; Boulahdour H; Blagosklonov O
    J Nucl Med; 2013 Mar; 54(3):358-63. PubMed ID: 23303963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serodiagnosis of alveolar echinococcosis: detection of antibody against EM18 in patients and rodents.
    Akira I
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 1():117-24. PubMed ID: 9656361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary disease recurrence after liver transplantation for alveolar echinococcosis: long-term evaluation in 15 patients.
    Bresson-Hadni S; Koch S; Beurton I; Vuitton DA; Bartholomot B; Hrusovsky S; Heyd B; Lenys D; Minello A; Becker MC; Vanlemmens C; Mantion GA; Miguet JP
    Hepatology; 1999 Oct; 30(4):857-64. PubMed ID: 10498634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized management of patients with inoperable alveolar echinococcosis undergoing treatment with albendazole: usefulness of positron-emission-tomography combined with serological and computed tomography follow-up.
    Crouzet J; Grenouillet F; Delabrousse E; Blagosklonov O; Thevenot T; Di Martino V; Piarroux R; Mantion GA; Bresson-Hadni S
    Clin Microbiol Infect; 2010 Jun; 16(6):788-91. PubMed ID: 19912267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET/CT helps to determine treatment duration in patients with resected as well as inoperable alveolar echinococcosis.
    Husmann L; Muehlematter UJ; Grimm F; Ledergerber B; Messerli M; Kudura K; Gruenig H; Muellhaupt B; Hasse B; Huellner MW
    Parasitol Int; 2021 Aug; 83():102356. PubMed ID: 33872794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should possible recurrence of disease contraindicate liver transplantation in patients with end-stage alveolar echinococcosis? A 20-year follow-up study.
    Bresson-Hadni S; Blagosklonov O; Knapp J; Grenouillet F; Sako Y; Delabrousse E; Brientini MP; Richou C; Minello A; Antonino AT; Gillet M; Ito A; Mantion GA; Vuitton DA
    Liver Transpl; 2011 Jul; 17(7):855-65. PubMed ID: 21455928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up PET/CT of alveolar echinococcosis: Comparison of metabolic activity and immunodiagnostic testing.
    Husmann L; Deibel A; Skawran S; Ledergerber B; Muehlematter UJ; Hasse B; Huellner MW; Reiner CS; Muellhaupt B
    PLoS One; 2022; 17(6):e0270695. PubMed ID: 35767557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of recombinant Em18-ELISA to evaluate efficacy of treatment in patients with alveolar echinococcosis.
    Fujimoto Y; Ito A; Ishikawa Y; Inoue M; Suzuki Y; Ohhira M; Ohtake T; Kohgo Y
    J Gastroenterol; 2005 Apr; 40(4):426-31. PubMed ID: 15870979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indications and results of liver transplantation for Echinococcus alveolar infection: an overview.
    Bresson-Hadni S; Koch S; Miguet JP; Gillet M; Mantion GA; Heyd B; Vuitton DA;
    Langenbecks Arch Surg; 2003 Sep; 388(4):231-8. PubMed ID: 12905036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an enzyme-linked immunosorbent assay (ELISA) with affinity-purified Em18 and an ELISA with recombinant Em18 for differential diagnosis of alveolar echinococcosis: results of a blind test.
    Ito A; Xiao N; Liance M; Sato MO; Sako Y; Mamuti W; Ishikawa Y; Nakao M; Yamasaki H; Nakaya K; Bardonnet K; Bresson-Hadni S; Vuitton DA
    J Clin Microbiol; 2002 Nov; 40(11):4161-5. PubMed ID: 12409391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes After Liver Resection for Hepatic Alveolar Echinococcosis: A Single-Center Cohort Study.
    Joliat GR; Melloul E; Petermann D; Demartines N; Gillet M; Uldry E; Halkic N
    World J Surg; 2015 Oct; 39(10):2529-34. PubMed ID: 26067633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Em18-immunoblot and Em18-ELISA for specific diagnosis of alveolar echinococcosis.
    Ito A; Sako Y; Yamasaki H; Mamuti W; Nakaya K; Nakao M; Ishikawa Y
    Acta Trop; 2003 Feb; 85(2):173-82. PubMed ID: 12606094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of metabolic activity in human alveolar echinococcosis using FDG-PET.
    Reuter S; Grüner B; Buck AK; Blumstein N; Kern P; Reske SN
    Nuklearmedizin; 2008; 47(4):147-52. PubMed ID: 18690373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience of liver transplantation for incurable alveolar echinococcosis: a 45-case European collaborative report.
    Koch S; Bresson-Hadni S; Miguet JP; Crumbach JP; Gillet M; Mantion GA; Heyd B; Vuitton DA; Minello A; Kurtz S;
    Transplantation; 2003 Mar; 75(6):856-63. PubMed ID: 12660515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the ELISA (Em2-Em18) and Western Blotting Methods on Diagnosis of Alveolar Echinococcosis.
    Demirkazık M; Koltas İS; İnceboz T; Korkmaz M; Gümürdülü D
    Turkiye Parazitol Derg; 2019 Oct; 43(Suppl 1):13-17. PubMed ID: 31591873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.